Structural mechanism underlying variations in DNA binding by the androgen receptor.

Androgen receptor Androgen response element Crystal structure DNA-binding domain Molecular Dynamics simulation X-ray crystallography

Journal

The Journal of steroid biochemistry and molecular biology
ISSN: 1879-1220
Titre abrégé: J Steroid Biochem Mol Biol
Pays: England
ID NLM: 9015483

Informations de publication

Date de publication:
09 Apr 2024
Historique:
received: 25 01 2024
revised: 12 03 2024
accepted: 13 03 2024
medline: 12 4 2024
pubmed: 12 4 2024
entrez: 11 4 2024
Statut: aheadofprint

Résumé

The androgen receptor (AR) is a steroid activated transcription factor which recognizes DNA motifs resembling inverted repeats of a conserved 5'-AGAACA-3'-like hexanucleotides separated by a three-nucleotide spacer from a similar, but less conserved hexanucleotide. Here, we report the structures of the human AR DNA binding domain (DBD) bound to two natural AREs (C3 and MTV) in head-to-head dimer conformations, diffracting at 2.05Å and 2.25Å, respectively. These structures help to explain the impact of androgen insensitivity mutations on the structure integrity, DNA binding and DBD dimerization. The binding affinity of the AR DBD to different DNA motifs were measured by the BioLayer Interferometry (BLI) and further validated by Molecular Dynamics (MD) simulations. This shows that the high binding affinity of the first DBD to the upstream 5'-AGAACA-3' motif induces the cooperative binding of the second DBD to the second hexanucleotide. Our data indicate identical interaction of the DBDs to the upstream hexanucleotides, while forming an induced closer contact of the second DBD on the non-canonical hexanucleotides. The variation in binding between the DBD monomers are the result of differences in DNA occupancy, protein-protein interactions, DNA binding affinity, and DNA binding energy profiles. We propose this has functional consequences.

Identifiants

pubmed: 38604378
pii: S0960-0760(24)00047-5
doi: 10.1016/j.jsbmb.2024.106499
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106499

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no competing interests in relation to this work. Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Xiao Yin Lee (XY)

Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, ON1 Herestraat 49 - box 901, Leuven, 3000, Belgium.

Wout Van Eynde (W)

Department of Chemistry, Laboratory of Biomolecular Modelling and Design, 3001, Heverlee, Belgium.

Christine Helsen (C)

Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, ON1 Herestraat 49 - box 901, Leuven, 3000, Belgium.

Hanne Willems (H)

Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, ON1 Herestraat 49 - box 901, Leuven, 3000, Belgium.

Kaat Peperstraete (K)

Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, ON1 Herestraat 49 - box 901, Leuven, 3000, Belgium; Department of Chemistry, Laboratory of Biomolecular Modelling and Design, 3001, Heverlee, Belgium.

Sofie De Block (S)

Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, ON1 Herestraat 49 - box 901, Leuven, 3000, Belgium.

Arnout Voet (A)

Department of Chemistry, Laboratory of Biomolecular Modelling and Design, 3001, Heverlee, Belgium.

Frank Claessens (F)

Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, ON1 Herestraat 49 - box 901, Leuven, 3000, Belgium. Electronic address: frank.claessens@kuleuven.be.

Classifications MeSH